Experimental study of [99mTc(PNP5) (DBODC)]+ as a new myocardial perfusion imaging agent

Cardiology

Volumn 112, Issue 2, 2008, Pages 89-97

  Zhang, Wan Chun ^a   Fang, Wei ^a   Li, Bin ^b   Wang, Xue Bin ^b   He, Zuo Xiang ^a  

^a FUWAI HOSPITAL   (China)

^b BEIJING NORMAL UNIVERSITY   (China)

Author keywords

99mTc(PNP5)(DBODC) +; Coronary disease; SPECT

Indexed keywords

ADENOSINE; BIS(DIMETHOXYPROPYLPHOSPHINOETHYL) ETHOXYETHYLAMINE BIS(N ETHOXYETHYL)DITHIOCARBAMATO]NITRIDE TECHNETIUM 99M; RADIOPHARMACEUTICAL AGENT; TRACER; UNCLASSIFIED DRUG; 99MTC N DBODC5; 99MTC-N-DBODC5; DIAGNOSTIC AGENT; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; ORGANOPHOSPHORUS COMPOUND; TECHNETIUM COMPLEX;

ANIMAL EXPERIMENT; ARTERY OCCLUSION; ARTICLE; BLOOD; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DOG; DRUG DISTRIBUTION; EXPERIMENTAL STUDY; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; IMAGE QUALITY; INFUSION; INJECTION; LIVER; NONHUMAN; PLASMA CLEARANCE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SWINE; ANIMAL; DISEASE MODEL; HEART; METHODOLOGY; MINIPIG; SCINTISCANNING;

ANIMALS; DISEASE MODELS, ANIMAL; DOGS; HEART; MYOCARDIAL ISCHEMIA; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; SWINE; SWINE, MINIATURE; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 58149086788     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000141013     Document Type: Article

References (21)

1. Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, O'Gara PT, Carabello BA, Russell RO Jr, Cerqueira MD, St John Sutton MG, DeMaria AN, Udelson JE, Kennedy JW, Verani MS, Williams KA, Antman EM, Smith SC Jr, Alpert JS, Gregoratos G, Anderson JL, Hiratzka LF, Faxon DP, Hunt SA, Fuster V, Jacobs AK, Gibbons RJ, Russell RO, American College of Cardiology; American Heart Association Task Force on Practice Guidelines, American Society for Nuclear Cardiology: ACC/AHA/ ASNC guidelines for the clinical use of cardiac radionuclide imaging - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/ AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). Circulation 2003;108:1404-1418.
2. O'Rourke RA, Brundage BH, Froelicher VF, Greenland P, Grundy SM, Hachamovitch R, Pohost GM, Shaw LJ, Weintraub WS, Winters WL Jr, Forrester JS, Douglas PS, Faxon DP, Fisher JD, Gregoratos G, Hochman JS, Hutter AM Jr, Kaul S, Wolk MJ: American College of Cardiology/American Heart Association Expert Consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. Circulation 2000;102:126-140.
3. Beller GA, Watson DD: Physiological basis of myocardial perfusion imaging with the technetium 99m agent. Semin Nucl Med 1991;21:173-181.
4. Kelly JD, Forster AM, Higley B, Archer CM, Booker FS, Canning LR, Chiu KW, Edwards B, Gill HK, McPartlin M, Nagle KR, Latham IA, Pickett RD, Storey AE, Webbon PM: Technetium-99m-tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging. J Nucl Med 1993;34:222-227.
5. Nakajima K, Taki J, Shuke N, Bunko H, Takata S, Hisada K: Myocardial perfusion imaging and dynamic analysis with technetium-99m tetrofosmin. J Nucl Med 1993;34:1478-1484.
6. Germano G, Chua T, Kiat H, Areeda JS, Berman DS: A quantitative phantom analysis of artifacts due to hepatic activity in technetium-99m myocardial perfusion SPECT studies. J Nucl Med 1994;35:356-359.
7. Nuyts J, Dupont P, Van den Maegdenbergh V, Vleugels S, Suetens P, Mortelmans L: A study of the liver-heart artifact in emission tomography. J Nucl Med 1995;36:133-139.
8. Kailasnath P, Sinusas AJ: Comparison of Tl-201 with Tc-99m-labeled myocardial perfusion agents: technical, physiologic and clinical issues. J Nucl Cardiol, 2001;8:482-498.
9. 99mTc heterocomplexes as hear imaging agents with improved biological properties. Nucl Med Commun 2002;23:689-693.
10. 99mTc-nitride heterocomplexes showing high heart uptake and improved imaging properties. J Nucl Med 2003;44:806-814.
11. 99mTc-tetrofosmin in rats. J Nucl Med 2004;45:2095-2101.
12. Marmion ME, Woulfe SR, Neumann WL, Nosco DL, Deutsch E: Preparation and characterization of technetium complexes with Schiff base and phosphine coordination. 1. Complexes of technetium-99g and -99m with substituted acac2en and trialkyl phosphines (where acac2en = N,N′-ethylenebis[acetylacetone iminato]). Nucl Med Biol 1999;26:755-770.
13. Bolzati C, Uccelli L, Boschi A, Malago E, Duatti A, Tisato F, Refosco F, Pasqualini R, Piffanelli A: Synthesis of a novel class of nitriido-Tc-99m radiopharmaceuticals with phosphino-thiol ligands showing transient heart uptake. Nucl Med Biol 2000;27:369-374.
14. Okada RD, Glover D, Gaffney T, Williams S: Myocardial kinetics of technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile. Circulation 1988;77:491-498.
15. Sansoy V, Glover DK, Watson DD, Ruiz M, Smith WH, Simanis JP, Beller GA: Comparison of thallium-201 resting redistribution with technetium-99m-sestamibi uptake and functional response to dobutamine for assessment of myocardial viability. Circulation 1995;92:994-1004.
16. Glover DK, Okada RD: Myocardial technetium 99m sestamibi kinetis after reperfusion in a canine model. Am Heart J 1993;125:657-666.
17. Piwnica-Worms D, Kronauge JF, Chiu ML: Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium(I) in cultured chick myocardial cells: mitochondrial and plasma membrane potential dependence. Circulation 1990;82:1826-1838.
18. Hatada K, Ruiz M, Riou LM, Lima RL, Goode AR, Watson DD, Beller GA, Glover DK: Organ biodistribution and myocardial uptake, washout, and redistribution kinetics of Tc-99m N-DBODC5 when injected during vasodilator stress in canine models of coronary stenoses. J Nucl Cardiol 2006;13:779-790.
19. 99mTc-sestamibi in the presence of total coronary artery occlusion. Am Heart J 1990;119:842-847.
20. 201Tl and regional myocardial blood flow. Circulation 1997;96:2332-2338.
21. 99mTc sestamibi uptake during adenosine-induced vasodilation as a function of coronary stenosis severity. Circulation 1995;91:813-820.